Showing results (391-400 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|January 1, 1996
Tissue distribution, metabolism and excretion of paclitaxel in miceA Sparreboom, O van Tellingen, W J Nooijen, et al.Anti-Cancer Drugs|July 1, 1995
Docetaxel: meeting the challenge of non-small cell lung cancer managementT Le ChevalierAnti-Cancer Drugs|January 1, 1997
Inhibition of the growth of 12V-ras-transformed rat fibroblasts by acetylsalicylic acid correlates with inhibition of NF-kappa BS Ljungdahl, M C Shoshan, S LinderAnti-Cancer Drugs|January 1, 1997
Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alphaJ Seong, C G Milross, N R Hunter, et al.Anti-Cancer Drugs|October 17, 1998
A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis. Ondansetron Acute Emesis Study GroupM Krzakowski, E Graham, L Goedhals, et al.Anti-Cancer Drugs|October 17, 1998
Synthesis and biological activity of gold and tin compounds in ovarian cancer cellsM Cagnoli, A Alama, F Barbieri, et al.Anti-Cancer Drugs|October 17, 1998
Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistanceA Harstrick, A Gonzales, N Schleucher, et al.Anti-Cancer Drugs|August 1, 1996
Optimal use of docetaxel (Taxotere): maximizing its potentialH A BurrisAnti-Cancer Drugs|August 1, 1996
Taxoids in combination chemotherapy for metastatic breast cancerV Dieras, P Fumoleau, H Bourgeois, et al.Anti-Cancer Drugs|July 1, 1996
Drug retention following intravesical delivery of fluorouracil therapeutic adhesive in C3H mouse bladderS S Singh, K M Smith, D M BrownPageof 464